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INTRODUCTION

Cl
− is the principal extracellular and intracellular anion for all vertebrate cells. Extracellular Cl − (Cl − out ) maintains bodily fluid and volume homeostasis and blood pressure and is thus fairly constant, except in disease states mainly associated with metabolic acidosis and alkalosis (1) regulates transporter function by modulating the activity of several protein kinases, such as WNK1 (with no lysine 1) (8), WNK4 (9), WNK3 (10), SPAK (Ste20p-related proline alanine-rich kinase) (11) , JNK (c-Jun N-terminal kinase), and p38 (12) , by binding directly to the kinases and modifying their activities. Thus, Cl − in regulates the activity of several transporters and channels in at least two ways. The activity of Cl − -coupled transporters is determined through changes in driving force. In addition, reduction in Cl − cotransporter 1) (13), NKCC2 (14) , and NCC (15) and several Na + -HCO 3 − cotransporters (NBCs) (16) by causing phosphorylation of the transporters by an unknown mechanism. Cl − in may directly interact with transporters to modulate their activity. However, the mechanisms by which Cl − in is sensed to modulate the activity of ion transporters are not well understood. Analysis of the ClC family of Cl − channels and transporters has identified GXXXP motifs as Cl − -sensing sites that participate in Cl − -mediated regulation of SLC26A2 (17) , NBCe1-B (also known as SLC4A4), and NBCe2-C (also known as SLC4A5) (16, (18) (19) (20) . In NBCe1-B, Cl − in is sensed by two GXXXP motifs, and both are required for inhibition of the NBCs by Cl − in between 5 and 60 mM. The first motif is 32 GXXXP 36 , which is located in the NBCe1-B autoinhibitory domain (AID; residues 1 to 40), and the second motif is 194 GXXXP 198 . NBCe1-B and other epithelial transporters that are functionally coupled to NBCe1-B to mediate epithelial fluid and electrolyte secretion, including CFTR, Slc26a6, KCC, NCC, and NKCC1, are regulated by multiple kinases and phosphatases (21) (22) (23) (24) . In secretory gland ducts, NBCe1-B, CFTR, and Slc26a6 are activated by IRBIT [inositol 1,4,5-trisphosphate (IP 3 ) receptor-binding protein released with IP 3 ] (16, (25) (26) (27) . IRBIT interacts with the AID in the N terminus of NBCe1-B to relieve autoinhibition by an unknown mechanism (25, 26) . NBCe1-B, CFTR, and Slc26a6 are regulated by the kinases WNK1 and WNK4, which phosphorylate and activate the kinase SPAK (26, 27) . Phosphorylation of NBCe1-B Ser 65 by SPAK inhibits the transporter, an effect that is reversed by the phosphatase PP1 (protein phosphatase 1) (28) . Key questions in understanding signaling by Cl − in are how Cl − in sensing by the GXXXP motifs is achieved, how IRBIT modulates regulation by Cl − in , and whether the kinase and phosphatase pathways interface with Cl − in and IRBIT to form an integrated signaling pathway. Moreover, it is not clear how interaction of IRBIT with the AID activates the transporters. Here, we used NBCe1-B as a model to address these questions by identifying the phosphorylation sites controlled by IRBIT, the kinases and phosphatases recruited by IRBIT to modify these sites, the effect of specific phosphorylation sites on Cl − in signaling, and the role of these sites in IRBIT-mediated relief of autoinhibition.
We report that IRBIT exposed the two cryptic N-terminal GXXXP motifs and recruited the kinases SPAK and calmodulindependent protein kinase II (CaMKII) or the phosphatases PP1 and calcineurin (CaN) to the AID of NBCe1-B. Liquid chromatographytandem mass spectrometry (LC-MS/MS) analysis of NBCe1-B serine and threonine phosphorylation sites identified 25 The indicated immunoprecipitates were prepared from lysates from HEK cells expressing NBCe1-B with or without IRBIT and were immunoblotted for the indicated kinases and phosphatases. In the controls (Con), precipitating antibodies were not added. (D) The means ± SEM of IRBIT-enhanced coimmunoprecipitates were determined from six similar experiments and normalized to coimmunoprecipitation in the absence of IRBIT. (E) Lysates from HEK cells transfected with IRBIT and CaN, CaMKII, PP1, or SPAK were incubated with partially purified Histagged NBCe1-B(1-95) or NBCe1-B(1-429) fragments, and pulldown experiments were performed. (F) The means ± SEM of the IRBIT-enhanced pulldown determined from three to four independent experiments and normalized to pulldown in the absence of IRBIT. AU, arbitrary units.
RESULTS
IRBIT interacts with and recruits PP1, CaN, CaMKII, and SPAK to NBCe1-B N terminus IRBIT interacts with PP1 (26, 29) and CaMKII (30) . We showed here that IRBIT coimmunoprecipitated with PP1, CaMKII, the phosphatase CaN, and the kinase SPAK (Fig. 1, A and B) . Moreover, IRBIT recruited the phosphatases and kinases to full-length NBCe1-B (Fig. 1, C and D) and, more specifically, to the N terminus of NBCe1-B(1-95) (Fig. 1, E and F) , which includes the AID of NBCe1-B. The entire NBCe1-B N-terminal domain (1 to 429) also showed IRBIT-dependent interaction of the phosphatases and kinases (Fig. 1, E Fig. 2A) . PP1 activates and SPAK inhibits NBCe1-B in an IRBIT-independent manner (26) , and the presence of IRBIT did not further activate NBCe1-B activated by PP1 (Fig. 2B) (Fig. 3C ). In addition, the NBCe1-B(S65A) mutation eliminated Cl − sensing by the 32 GXXXP 36 motif (Fig. 3D) . Last, because PP1 dephosphorylates Ser . Localization of the phosphorylation sites in the N terminus of NBCe1-B and the orientation of these sites with respect to the GXXXP motifs and the iontransporting sector of NBCe1-B are shown in the structural model of NBCe1-B ( fig. S4 ). All three phosphorylation sites are conserved in the kidney-specific isoform NBCe1-A, and the first phosphorylation site (equivalent to Ser 232 in NBCe1-B) is conserved in all members of the NBC family ( fig. S5 ). 12 to a nonphosphorylatable residue [NBCe1-B(S12A)] or a phosphomimetic residue [NBCe1-B(S12D)] did not affect the surface expression of NBCe1-B or its interaction with IRBIT ( Fig. 5A) . At 5 mM Cl − in , the S12A mutation did not affect NBCe1-B activity in the absence of IRBIT (Fig. 5B ) and had a small stimulatory effect in the presence of IRBIT (Fig. 5C ), whereas the S12D mutation increased NBCe1-B activity in the presence or absence of IRBIT by about 60% (Fig. 5, B and C) . By contrast, the S12D mutation did not affect the inhibition of IRBIT-activated NBCe1-B by Cl − in , whereas the S12A mutation increased the Cl − in required for inhibition at the high millimolar range (Fig. 5, C and D was studied by mutating them individually and in combination to alanine or to aspartate residues. The combined and individual mutations had no obvious effect on NBCe1-B total and surface expression or interaction with IRBIT (Fig. 6, A and B) . However, mutating all three serine residues to alanine residues [NBCe1-B(AAA)] resulted in fully activated NBCe1-B that was not activated further by IRBIT (Fig. 6C) . On the other hand, mutating all three serine residues to aspartate residues [NBCe1-B(DDD)] nearly completely inhibited NBCe1-B activity, which could not be rescued or activated by IRBIT (Fig. 6C) . To further confirm that NBCe1-B(AAA) and NBCe1-B(DDD) function was independent of IRBIT, we mutated the three serine residues in NBCe1-B(1-95), which lacks the autoinhibitory IRBIT-binding domain (28, 34) . The AAA mutation also maximized the activity of NBCe1-B(1-95), whereas the DDD mutation markedly inhibited NBCe1-B(1-95) activity (Fig. 6C ). In addition, we mutated the analogous three residues in NBCe1-A, which functions independently of IRBIT. NBCe1-A activity was increased by the AAA mutation and inhibited by the DDD mutation (Fig. 6C) (Fig. 6D) are phosphorylated) resulted in activation of NBCe1-B, which was further increased by IRBIT (Fig. 6D ). S232D and S233D minimally affected basal NBCe1-B activity but eliminated activation by IRBIT. By contrast, the S235D mutation substantially inhibited basal NBCe1-B activity, but the residual activity was activated by IRBIT to a similar extent as wild-type NBCe1-B (Fig. 6, C and D) . Thus, inhibition of NBCe1-B by the phosphomimetic aspartate mutations was independent of IRBIT. Mutation of these residues in NBCe1-B(1-95) did not affect surface expression ( fig. S6A ) but caused inhibition of NBCe1-B(1-95) current similar to that of full-length NBCe1-B (fig. S6B ).
The decoupling of NBCe1-B activity from IRBIT caused by mutating Ser 232 raised the question of the role played by Ser 232 and this region of NBCe1-B in the activation of the cotransporter. We addressed this question by mutating Ser 232 to various residues. All mutations tested were tolerated and did not affect NBCe1-B total and surface expression or interaction with IRBIT ( fig. S7A ). Measurement of NBCe1-B activity showed that adding a negative charge at Ser 232 (Asp and Glu) resulted in inhibition of transport and loss (S232D) or reduced (S232E) activation by IRBIT ( fig. S7B ). Replacing Ser 232 with residues that can be phosphorylated by kinases (Thr and Tyr) did not restore the wild-type phenotype but resulted in a phenotype similar to S232A. A positive charge (Lys), a polar residue (Gln), a small residue (Leu), and a bulky (Trp) hydrophobic residue resulted in a phenotype similar to that of S232A. Residues that introduce kinks (Gly and Pro) were less effective in activating NBCe1-B but resulted in maximal activation by IRBIT. These findings suggest that Ser 232 is in a conformation-sensitive region of the protein and that IRBIT limits the phosphorylation of this site to stabilize an active conformation. The equivalent Ser 232 is conserved in NBCe2-C ( fig. S5) , and introducing the equivalent mutation NBCe2-C(S236D) reduced transport activity ( fig. S8, A and B) . Together, the findings suggest that the phosphorylation state of Ser 232 determines whether NBCe1-B is in an active or inactive conformation and that by binding to the AID, IRBIT activates NBCe1-B by limiting the dephosphorylation of this site. showed that activation of the current did not affect the reversal potential, and thus ion selectivity, of NBCe1-B (Fig. 7A) (Fig. 7C) . The actual and normalized currents of NBCe1-B(S235A) (Fig. 7D) showed that in the absence of IRBIT, the increased activity of NBCe1-B(S235A) was inhibited by 140 mM, but not by 40 mM Cl (Fig. 7D) . The inhibition followed a shallower curve than that observed with NBCe1-B activated by transfection with IRBIT complementary DNA (cDNA) (1 g/ml; for example, Figs. 2C and 5C). We reason that this effect may be due to the maximal activity observed with NBCe1-B(S235A) activated by IRBIT. Transfecting the cells with wild-type NBCe1-B and a large amount of IRBIT resulted in a Cl − in inhibitory curve similar to that observed with NBCe1-B(S235A) stimulated by IRBIT (Fig. 7D) . These findings suggest that inhibition by Cl 
DISCUSSION
Cl
− is the major anion and an important osmolyte in most living cells and has a prominent role in cellular homeostasis by affecting cytoplasmic ionic composition, pH, cell volume, and the membrane potential. These roles are related mostly to the transport function of Cl (35, 36) , the anion exchanger AE1 (37) , and the SLC26 transporters Slc26a5 (also known as prestin) (38), Slc26a1, and Slc26a2 (17, 39) . Cl − is sensed by a GXXXP motif in Slc26a2 (17) . The family of cotransporters and exchangers has one or more GXXXP motifs, and Cl In the basal state, NBCe1-B has low activity due to inhibition by its AID, a conformation in which the two Cl − in -sensing GXXXP motifs are not accessible. In the resting state, IRBIT is sequestered by binding to IP 3 receptors (IP 3 Rs) (27, 40) . Upon cell stimulation, IRBIT is released from the IP 3 Rs and interacts with and activates NBCe1-B and other epithelial transporters (27) (Fig. 7E, conformation A) . This conformation is active independently of autoinhibition and Cl − independent inhibition, as demonstrated by the findings that mutation of Ser 232 to any residue, except for the phosphomimetic Asp and Glu, resulted in partial or full activation of NBCe1-B independent of IRBIT, and that similar activation was observed with the CA NBCe1-B mutant lacking the AID [NBCe1-B(1-95)] and NBCe1-A (Fig. 6, C and D, and fig. S7B ). Moreover, mutation of Ser 232 to Asp or Glu inhibited NBCe1-B, NBCe1-B(1-95), and NBCe1-A without affecting the interaction with IRBIT or the surface expression of the transporter [ Fig. 6 (A to D) and figs. S6 (A and B) and S7 (A and B) ]. Together, these findings suggest that Ser 232 controls the communication between the large cytoplasmic N terminus and the transmembrane sector of NBCe1-B to affect opening of the permeation pathway.
The second IRBIT-induced NBCe1-B conformation is phosphorylated at Ser 232 and Ser 235 (Fig. 7E, conformation B) . The properties of conformation B are similar to those of wild-type NBCe1-B. It is inactive in the absence of IRBIT with cryptic Cl (24) to inhibit SPAK activity. However, the effect that Cl − between 5 and 20 mM has on SPAK activity is unclear, and the concentrations at which SPAK affects Cl − regulation of NBCe1-B are not known. Our findings have broad physiological implications by demonstrating that multiple phosphorylation sites are used to fine-tune transporter activity to meet variable demands. A good example is fluid and HCO 3 − secretion by stimulated pancreatic and salivary ducts, which secrete fluid containing 140 mM HCO 3 − (21). As fluid and HCO 3 − secretion progresses from the intercalated duct to the intralobular duct and to the main duct, secretion occurs at increased luminal HCO 3 − concentration and thus requires enhanced basolateral HCO 3 − influx. The duct cells likely use combinations of phosphorylation sites to tune HCO 3 − influx by NBCe1-B, depending on their position in the duct. It is likely that in the intercalated duct, Ser 
MATERIALS AND METHODS
Plasmids
The p3xFLAG-CMV-7.1/IRBIT, pCMV-HA-IRBIT, pEGFP-C1/ NBCe1-B, pEGFP-C1/NBCe2-C, and pCDNA 3.1+/NBCe1-A constructs were described previously (28) . pCDNA3-Flag CaN was a gift from R. Bassel-Duby and E. Olson (University of Texas Southwestern Medical Center), pCDNA-CaMKII was a gift from L. Nutt (St. Jude Children's Research Hospital, Memphis), and pCDNA3/ mPP1 was a gift from E. Delpire (Vanderbilt University Medical Center, Nashville). The cDNA encoding SPAK (a gift from M. Cobb, University of Texas Southwestern Medical Center) was excised from the original vectors and transferred to pCMV-myc. Point mutations were generated by site-directed mutagenesis with a Quick light chain mutagenesis kit (Agilent), using primers to change specific regions. All constructs were verified by sequencing of the entire open reading frames.
Surface expression and coimmunoprecipitation
Biotinylation of surface proteins was performed by incubating transfected HEK cells with EZ-LINK Sulfo-NHS-LC-biotin (0.5 mg/ml; Thermo Fisher Scientific) for 30 min on ice. The cells were then treated with 100 mM glycine for 10 min to terminate the biotinylation reaction, washed with phosphate-buffered saline, and lysed with icecold lysis buffer [10 mM NaPO 4 3− , 137 mM NaCl, 2.7 mM KCl, 50 mM NaF, 1% Triton X-100, and protease inhibitor cocktail (Roche)] for 20 min on ice. After brief sonication, lysates were collected by centrifugation. Biotinylated proteins were captured with avidin beads (Thermo Fisher Scientific) by incubation for 1 hour at 4°C. The precipitated proteins were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). Coimmunoprecipitation was performed by incubation overnight of 300 g of proteins with corresponding antibodies for each protein: NBCe1-B [anti-GFP (green fluorescent protein), A11122, Invitrogen], IRBIT [anti-HA (hemagglutinin), 2367S, Cell Signaling], CaN (anti-FLAG, F3165, Sigma) anti-MYC (2276S, Cell Signaling), and CAMKII (13141, Santa Cruz). The next day, Protein G Sepharose beads (GE Healthcare) are added and incubated for 2 hours at 4°C. Beads were collected by centrifugation and washed three times with lysis buffer, and proteins were recovered by 30-min heating at 56°C in SDS sample buffer. Proteins were subjected to SDS-PAGE, and the blots probed for the indicated proteins.
Pulldown experiments
The N-terminal 95 (1 to 95) amino acids and 429 amino acids (1 to 429) of NBCe1-B were subcloned in the pQE-TriSystem His-Strep vector (Qiagen). The final plasmid constructs were transformed into the Escherichia coli strain Rosetta (DE3) competent cells. Colonies were amplified in 10 ml of LB medium containing ampicillin (100 ug/ml) and incubated at 37°C overnight under shaking (250 rpm). Aliquots were then used to inoculate larger volume cultures. Protein expression was induced until the OD 600 (optical density at 600 nm) of the culture reached 0.6 by the addition of isopropyl--d-thiogalactopyranoside to a final concentration of 0.1 mM. Histagged proteins were extracted by lysis and sonication, and extracts were clarified by centrifugation at 20,000g for 20 min. Fusion proteins were purified with Ni-NTA superflow beads (Qiagen). Purity of proteins was better than 80%, as determined by Coomassie Blue staining. HEK cell lysates expressing NBCe1-B and the kinases or phosphatases as indicated were incubated with Strep-tagged fusion proteins bound to the beads for 4 hours at 4°C. The beads were washed with lysis buffer, and proteins were released by incubation in SDS sample buffer at 56°C for 20 min and analyzed by SDS-PAGE and Western blotting.
Determination of NBCe1-B phosphorylation site
Cells expressing NBCe1-B alone or NBCe1-B and IRBIT were lysed with 8 M urea and sonicated. The cell lysates were reduced by the addition of 20 mM dithiothreitol, alkylated with 40 mM iodoacetamide, and diluted with 20 mM triethylammonium bicarbonate buffer (pH 8.5) to reduce urea to 1 M. The lysates were then digested with trypsin (enzyme, Promega) at a lysate/trypsin ratio of 1:20. Peptides were desalted using hydrophilic-lipophilic-balanced extraction cartridges (Oasis) and then subjected to phosphopeptide enrichment using either Fe-NTA or TiO 2 columns as per the manufacturer's protocol (Thermo Fisher Scientific). The enriched peptides were desalted using graphite columns, vacuum-dried, and stored at −80°C. Peptides were resuspended with 0.1% formic acid for mass spectrometry (Orbitrap Fusion ETD mass spectrometer, Thermo Fisher Scientific) analysis. Mass Spec spectra were analyzed using Proteome Discoverer 1.4 software (Thermo Fisher Scientific). Peptide-spectra matching (false discovery rate, <0.01; peptide rank, 1) was analyzed by both Mascot and Sequest HT software and the human Swiss-prot (18 November 2016) protein database. The probabilities of the phosphorylation site localizations were calculated using the phosphoRS 3.1 Module within Proteome Discoverer 1.4. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD010598.
Current measurement in HEK-293 cells
The effect of Cl − in on current mediated by NBCe1-B, NBCe1-A, and NBCe2-C activity was analyzed in transiently transfected HEK-293 cells using whole-cell current recording at room temperature, exactly as detailed previously (16) , and varying the pipette Cl − concentration between 5 and 140 mM. Patch pipettes had a resistance of 5 to 7 megohms when filled with CsCl-based pipette solution. The cell capacitance was between 10 and 18 pF. The pipette solutions contained 2 mM MgSO 4 , 1 mM adenosine 5′-triphosphate, 0.5 mM EGTA, 10 mM Hepes, and a mixture of CsCl and Cs-gluconate to yield Cl − concentrations of 5, 10, 20, 30, 40, and 140 mM. pH was adjusted to 7.3 with CsOH. The Hepes-buffered bath solution contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10 mM glucose, and 10 mM Hepes (pH 7.4 with NaOH). The HCO 3 − -buffered solution was prepared by replacing 25 mM NaCl with equimolar amount of NaHCO 3 , and the solution was equilibrated with 5% CO 2 /95% O 2 . The current was recorded by 400-ms rapid alteration of membrane potential from −60 to +60 mV every 2 s from a holding potential of 0 mV. Before current recording, the junction potential at each pipetted solution Cl − concentration was offset to 0 using the Axopatch 200B amplifier. The current recorded at +60 mV was used to calculate current density as picoampere/picofarad. Axopatch 200B patch-clamp amplifier, Digidata -1440A, and pClamp 10 software (Molecular Devices) were used for data acquisition and analysis. The currents were filtered at 1 kHz and sampled at 10 kHz.
Preparation of cRNA
The human NBCe1-B/pcDNA3.1 and human IRBIT/pcDNA3.1 plasmids were used as templates for preparation of the corresponding cRNAs. DNA was linearized with SmaI (NBCe1-B) or Xba1 (IRBIT) (New England Biolabs, Ipswich, MA). cRNA was then transcribed in vitro using a T7 PNA polymerase kit (mMessage mMachine T7 Kit; Ambion Inc., Austin, TX). cRNA was purified by phenol/chloroform extraction, precipitated with isopropanol, and then dissolved in nuclease-free water (Ambion Inc., Austin, TX). -free OR-2. Healthy oocytes in stages V to VI were collected under a microscope and maintained at 18°C overnight in ND96 solution [96.0 mM NaCl, 2.0 mM KCl, 1.8 mM CaCl 2 , 1.0 mM MgCl 2 , 2.5 mM sodium pyruvate, 5.0 mM Hepes-Na (pH 7.5), streptomycin (100 g/ml), and penicillin (100 U/ml)]. Oocytes were injected with the indicated amount of cRNA in a final volume of 50 nl using a Nanoliter 2000 injector (World Precision Instruments Inc., Sarasota, FL). Oocytes were incubated at 18°C in ND96 solution with pyruvate and antibiotics. The medium was changed everyday, and oocytes were tested 48 to 96 hours after cRNA injection.
Preparation and injection of Xenopus oocytes
Measurement of membrane current and voltage in oocytes
Electrophysiological recordings were performed at room temperature with two-electrode voltage clamp or current clamp using an OC-725C Oocyte Clamp System (Warner Instruments Corp., Hamden, CT). The microelectrodes were filled with 3 M KCl (resistance, 0.5 to 2 megohms). During recording, the oocytes were superfused with ND96 solution. The Cl − and HCO 3 − -containing solutions were of 71.0 mM NaCl, 25.0 mM NaCl or NaHCO 3 , 2.0 mM KCl, 1.8 mM CaCl 2 , 1.0 mM MgCl 2 , and 5.0 mM Hepes-Na (pH 7.5). Solutions were constantly gassed with 5% CO 2 /95% O 2 . Current and voltage were digitized via a Digidata 1322A A/D converter (Axon Instrument, Foster City, CA) and analyzed using Clampex 8.1 system.
Structure prediction and protein modeling
A segment of mouse NBCe1-B, consisting of 1000 amino acids (NP_061230.2), was submitted to both ROBETTA and hhPRED.
The ROBETTA software generated different models for three segments of the submitted sequence. No homology was identified for segment 1-106. Segment 107-413 was homologous to Putative Substrate Access Tunnel in the Cytosolic Domain of Human Anion Exchanger 1 (Protein Data Bank ID: 4KY9), which is similar to human erythrocyte band 3 cytoplasmic domain (Protein Data Bank ID: 1HYN) that we previously used to predict NBCe1-B N terminus (16) , and the same structure is used here. The transmembrane segment spanning residues 414 to 1000 was found to be homologous to the structure of the anion exchanger domain of human erythrocyte band 3 (Protein Data Bank ID: 4YZF). The highest transmembrane domain (TMD) homology score provided by the hhPRED software was for the Electrogenic sodium bicarbonate cotransporter 1, NBCe1 (PDB_ID 6CAA). (Probability, 100; E value, 2.5 × 10 −164
; SS,108.9; Cols,1003). The NBCe1 TMD structure has been recently solved by cryo-electron microscopy (CryoEM) (41) . The final model was generated with PyMOL using the TMD obtained of the CryoEM structure, and the intracellular domains were predicted by hhPRED and ROBETTA based on the N-terminal domain of AE1. The orientation of the N terminus with respect to the TMD is not known with certainty and may not be accurate. However, the overall structure is reasonable because the software identified the N terminus of AE1 as the best template, which, like NBCe1-B, is a member of the SLC4 transporters superfamily. In addition, we have previously predicted the structure of NBCe1-B to be similar to the crystal structure of UraA (16) , which is similar to the crystal structure of AE1. This indicates that the software predicted the same structure twice and independently on the basis of several similar, yet different structures.
Statistics
Results are given as means ± SEM, and statistical significance was analyzed by Student's t test or two-way analysis of variance (ANOVA), as appropriate.
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